Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.
2019-12-10

2019. Wei J1, Long L, Zheng W, Dhungana Y, Lim S1, Guy C, Wang Y, Wang YD, Qian C, Xu B, Kc A, Saravia J, Huang H, Yu J, Doench JG, Geiger TL, Chi H. Nature, DOI: 10.1038/s41586-019-1821-z. [Epub ahead of print]